Last reviewed · How we verify

NCT04264013: EVEN-P

The Eggs and actiVity in hEalth agiNg Pilot (EVEN-P) Trial in Older Persons

Withdrawn NA Last updated 14 March 2023
What this trial tests

NA trial testing Exercise in Aging. Withdrawn.

Timeline
1 May 2020
Primary endpoint
1 March 2021
1 May 2021

Quick facts

Lead sponsorMcMaster University
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposebasic science
Start date1 May 2020
Primary completion1 March 2021
Estimated completion1 May 2021
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

McMaster University

Who can join

Adults 60 to 75, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Two of the most effective lifestyle-based approaches to reduce the risk of adverse health events and enhance quality of life with aging are exercise and a healthy diet. Currently, the Canadian recommended dietary allowance (RDA) for protein is 0.8 g/kg/day, however, several expert groups have advocated for a higher RDA of protein (\~1.2 g/kg/day), along with more evenly distributed daily consumption, in older persons. Eggs are considered a nutrient-rich protein source but have recently been scrutinized. This study will compare a high-protein, egg-containing diet and a high-protein, non-egg diet in healthy older persons.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Aging

Currently open trials in the same condition.

Other McMaster University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04264013.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing